| Update on fecal microbiota transplantation 2015: indications, methodologies, mechanisms, and outlook CR Kelly, S Kahn, P Kashyap, L Laine, D Rubin, A Atreja, T Moore, G Wu Gastroenterology 149 (1), 223-237, 2015 | 709 | 2015 |
| Antibiotics associated with increased risk of new-onset Crohn’s disease but not ulcerative colitis: a meta-analysis R Ungaro, CN Bernstein, R Gearry, A Hviid, KL Kolho, MP Kronman, ... Official journal of the American College of Gastroenterology| ACG 109 (11 …, 2014 | 514 | 2014 |
| Strategies to enhance patient adherence: making it simple A Atreja, N Bellam, SR Levy Medscape General Medicine 7 (1), 4, 2005 | 392 | 2005 |
| Telemedicine across the globe-position paper from the COVID-19 pandemic health system resilience PROGRAM (REPROGRAM) international consortium (Part 1) S Bhaskar, S Bradley, VK Chattu, A Adisesh, A Nurtazina, S Kyrykbayeva, ... Frontiers in public health 8, 556720, 2020 | 319 | 2020 |
| A pooled analysis of efficacy, safety, and long-term outcome of endoscopic balloon dilation therapy for patients with stricturing Crohn's disease D Bettenworth, A Gustavsson, A Atreja, R Lopez, C Tysk, G Van Assche, ... Inflammatory bowel diseases 23 (1), 133-142, 2017 | 254 | 2017 |
| Potentially inappropriate medication prescribing in outpatient practices: prevalence and patient characteristics based on electronic health records MD Buck, A Atreja, CP Brunker, A Jain, TT Suh, RM Palmer, DA Dorr, ... The American journal of geriatric pharmacotherapy 7 (2), 84-92, 2009 | 188 | 2009 |
| Fecal microbiota transplantation is highly effective in real-world practice: initial results from the FMT national registry CR Kelly, EF Yen, AM Grinspan, SA Kahn, A Atreja, JD Lewis, TA Moore, ... Gastroenterology 160 (1), 183-192. e3, 2021 | 187 | 2021 |
| Gut microbiota density influences host physiology and is shaped by host and microbial factors EJ Contijoch, GJ Britton, C Yang, I Mogno, Z Li, R Ng, SR Llewellyn, ... elife 8, e40553, 2019 | 185 | 2019 |
| 2017 Roadmap for innovation—ACC health policy statement on healthcare transformation in the era of digital health, big data, and precision health: a report of the American … SP Bhavnani, K Parakh, A Atreja, R Druz, GN Graham, SS Hayek, ... Journal of the American College of Cardiology 70 (21), 2696-2718, 2017 | 185 | 2017 |
| The risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin … KM Pantalone, MW Kattan, C Yu, BJ Wells, S Arrigain, A Jain, A Atreja, ... Acta diabetologica 46, 145-154, 2009 | 164 | 2009 |
| Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response L Katz, JP Gisbert, B Manoogian, K Lin, C Steenholdt, GJ Mantzaris, ... Inflammatory bowel diseases 18 (11), 2026-2033, 2012 | 160 | 2012 |
| The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis KM Pantalone, MW Kattan, C Yu, BJ Wells, S Arrigain, A Jain, A Atreja, ... Diabetes care 33 (6), 1224-1229, 2010 | 145 | 2010 |
| Increase in overall mortality risk in patients with type 2 diabetes receiving glipizide, glyburide or glimepiride monotherapy versus metformin: a retrospective analysis KM Pantalone, MW Kattan, C Yu, BJ Wells, S Arrigain, A Jain, A Atreja, ... Diabetes, Obesity and Metabolism 14 (9), 803-809, 2012 | 136 | 2012 |
| Is liver transplantation a risk factor for cardiovascular disease? A meta‐analysis of observational studies S Madhwal, A Atreja, M Albeldawdi, R Lopez, A Post, MA Costa Liver transplantation 18 (10), 1140-1146, 2012 | 133 | 2012 |
| Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis BV John, R Konjeti, A Aggarwal, R Lopez, A Atreja, C Miller, NN Zein, ... Annals of hepatology 12 (6), 952-958, 2013 | 114 | 2013 |
| White paper AGA: the impact of mental and psychosocial factors on the care of patients with inflammatory bowel disease EM Szigethy, JI Allen, M Reiss, W Cohen, LP Perera, L Brillstein, ... Clinical Gastroenterology and Hepatology 15 (7), 986-997, 2017 | 113 | 2017 |
| Safety and efficacy of endoscopic dilation for primary and anastomotic Crohn's disease strictures A Atreja, A Aggarwal, S Dwivedi, F Rieder, R Lopez, BA Lashner, ... Journal of Crohn's and Colitis 8 (5), 392-400, 2014 | 112 | 2014 |
| Spontaneous bacterial peritonitis: recent data on incidence and treatment MA Parsi, A Atreja, NN Zein Cleveland Clinic Journal of Medicine 71 (7), 569-577, 2004 | 109 | 2004 |
| Statins associated with decreased risk of new onset inflammatory bowel disease R Ungaro, HL Chang, J Cote-Daigneaut, S Mehandru, A Atreja, ... Official journal of the American College of Gastroenterology| ACG 111 (10 …, 2016 | 88 | 2016 |
| Web-based self-management for patients with multiple sclerosis: a practical, randomized trial DM Miller, SM Moore, RJ Fox, A Atreja, AZ Fu, JC Lee, W Saupe, ... Telemedicine and e-Health 17 (1), 5-13, 2011 | 87 | 2011 |
Aimee LucasIcahn School of Medicine at Mount SinaiPotvrđena adresa e-pošte na mssm.edu
